WSJ : The Fed Aims to Repeat Greenspan’s 1990s Masterpiece

The Fed Aims to Repeat Greenspan’s 1990s Masterpiece
The 1995 cuts helped lay the groundwork for a soft landing and the late ’90s boom years

The Federal Reserve famously guided the economy to a soft landing in 1995, paving the way for the economic boom that followed. Can it do so again? With Wednesday’s sizable rate cut, it is off to a good start.

In 1994, the Fed raised rates aggressively to tackle inflationary pressures. By 1995, the labor market was clearly cooling. Then, as now, there weren’t signs of an imminent recession. But in May 1995 there was a negative reading for monthly jobs, helping push the Fed to the first of three cuts the following month.

That scary number turned out to be an anomaly—jobs bounced back the following month. But looking at a three-month moving average to smooth out volatility, the cooling trend was clear. In the three months through June 1995, the economy of that time had added an average of 126,000 jobs, down from an average of 332,000 in the three-month period a year before.

Fast forward to 2024: Jobs figures have again been bouncing around month-to-month, but in the three months through August, job creation averaged 116,000 a month, compared with 211,000 a year earlier.

The Fed’s three quarter-point rate cuts in 1995 and early 1996 succeeded: By mid-1996 job creation had rebounded to average around 250,000 a month, and inflation didn’t become a major concern for a long while after.

Why then has the Fed opted to start its easing program this time around with a more aggressive 50-basis-point cut? It isn’t, as some have fretted, that the Fed sees much bigger economic risks than the rest of us in the economy today. In fact, Fed Chair Jerome Powell sounded fairly positive in Wednesday afternoon’s press conference. “The U.S. economy is basically fine,” he said. “Our intention is really to maintain the strength that we currently see in the U.S. economy.”

Instead, it has to do with fundamental differences between the economy and the rate environment of the 1990s and those of today.

In 1995, the era of ultralow rates that began in the early 21st century hadn’t yet been dreamed of. When Alan Greenspan’s Fed started hiking rates in 1994, it brought them from 3% at the start of that year to 6% in February 1995. By contrast, in the Fed’s tightening cycle this time around, rates started at a range of between 0% to 0.25% in early 2022 and came all the way up to 5.25% to 5.5% by July 2023. The degree of tightening, in other words, was far greater this time.

The relative stance of policy is tighter as well. As TS Lombard economist Dario Perkins observed in a note this week, Greenspan had argued around 1995 that the so-called “neutral rate” was just three-quarters of a point below where the Fed was in June of that year. This is essentially the theoretical rate of interest that the Fed believes allows employment to be as high as possible while inflation is within target range. Three quarter-point cuts turned out to be just what the doctor ordered for the economy at the time.

While there is widespread debate over the current neutral rate, most economists believe it to be far lower, meaning the economy is less able to absorb high rates today than it was three decades ago. This could be due to a number of factors, including demographics, differences in productivity growth and changes to the financial system.

Powell on Wednesday said he doesn’t know what the current neutral rate is, except that he believes it is “significantly higher” than when it was around zero or even negative, such as at times before the pandemic.

Still, the “longer term” fed-funds rate forecast by Fed policymakers in their summary of economic projections gives some indication where the central bank believes it may be. This inched up to 2.9% in the latest projections from 2.8% in June. But that is still a long way from the current policy range after Wednesday’s cut to 4.75% to 5.0%.

What this means is that, following the postpandemic inflationary surge, the Fed has kept rates at what, by its own estimates, amount to extraordinarily restrictive levels. They have a long way to go to get them back to a level that isn’t holding the economy back. This helps explain not only why they opted to begin this easing cycle with a bang, but also why their projections imply two more quarter-point cuts this year and another full percentage point of reductions next year.

The Fed of the mid-1990s kept itself ahead of the curve and prevented a downturn. Powell’s Fed today is seeking to do the same. Considering where it is starting from, it has to move faster this time.

FT : Sotheby’s secures beauty mogul’s $200mn collection

Sotheby’s secures beauty mogul’s $200mn collection
India Art Fair to open in Mumbai; praise for Vienna fair’s new director; London galleries join forces for shows

Sotheby’s has won the right to sell the $200mn art collection of Palm Beach beauty businesswoman Sydell Miller, who died in February. With her husband, Arnold, she co-founded the false-eyelash company Ardell and the salon product business Matrix Essentials, which she sold to Bristol Myers Squibb in 1994 (it is now part of L’Oréal).

Miller, by then widowed, turned to collecting around this time and bought across a range of styles, including French 18th-century furniture, 20th-century European design and Modern and contemporary art. The cream of the Miller crop, about 25 works, will be offered in a single-owner sale in New York in the week of November 18, topped by a late water lily painting by Claude Monet, “Nymphéas” (c1914-17), estimated at around $60mn. Pablo Picasso’s painting “La Statuaire” (1925), which Miller bought at auction in 1999 for $11.8mn, will be offered at about $30mn. Design highlights include a 2001 octagonal table incorporating a herd of gilded elephants by François-Xavier Lalanne, which Miller commissioned (est $4mn-$6mn).

Jodi Pollack, Sotheby’s worldwide co-head of 20th-century design, describes Miller as “a trailblazer” in that “she really leaned into the integration of art, design and objects, a trend we see more of today”. The collection, which is not guaranteed, comes to a market in need of a boost — global auction sales fell 27 per cent in the first half of this year compared with 2023, according to ArtTactic.

The organisers of Delhi’s India Art Fair are launching a contemporary art and design event in Mumbai, to run November 13-16 2025. “Mumbai is a film, entertainment and financial capital, with a diverse cultural community, and has seen a rise of private galleries and institutions in the past few years,” says Jaya Asokan, director of what is now known as India Art Fair Delhi and the new India Art Fair Contemporary. Recently founded institutions include the Nita Mukesh Ambani Cultural Centre, which opened last year. The new fair will be nearby in the wealthy family’s Jio World Garden venue.

The timing of the latest fair, planned for 50-70 exhibitors, means it will probably coincide with the boutique Art Mumbai, which launched successfully last November. Asokan says her hope is that the events will overlap (Art Mumbai has yet to confirm its dates for 2025). “As in London, New York and Hong Kong, Mumbai could have a dedicated moment in the international calendar,” she says.

This year, Mumbai overtook Beijing as the city with the most billionaires in Asia, according to the Hurun Research Institute. The Delhi fair, owned by Angus Montgomery Arts, has helped stimulate a revival of India’s art market in the past few years and runs its 16th edition in February 2025. 

Torrential rainstorms didn’t spoil the efforts of viennacontemporary’s new director, Francesca Gavin, to revitalise this fair as a distinct showing of art from central Europe (September 12-15). Of the 98 exhibiting galleries at this 10th edition, nearly half were from Austria, with 20 other countries, including Lithuania, Hungary, Romania and Slovakia, also represented.

“When people think of Vienna, they think of its history, but I want them to see the vitality of its contemporary art scene and for the fair to reflect the city’s increasingly young and Balkan communities,” Gavin says. Exhibitors from Germany and Italy show how “it’s not just about the east. If you stick a pin in the middle of Europe, you get where we are,” she adds.

The pace of sales was slow, although some exhibitors, including Budapest’s Ani Molnár, fared well with artists such as the late Tamás Konok (four works sold for between €2,800 and €5,000 each early on). “There are so many Hungarian collectors here. Vienna is only a three-hour drive away and they want to see us in a good quality fair,” Molnár said. Even when sales weren’t immediate, gallerists were glad to be in the fold. “We are from Slovenia. We don’t have a market at all there — this is a hundred times better,” said Uroš Legen, gallery manager of Ljubljana’s P74.

The fatal storms, which ravaged central Europe last week, forced the closure of the coinciding Parallel Vienna fair in the Otto Wagner Areal on September 15, but organisers have extended its hours to this weekend.

Also opening in Vienna last week was the month-long Curated By gallery festival, supported with €250,000 from the city of Vienna and Austria’s ministry of culture. Their funding helps 24 of the city’s galleries host shows organised by outside curators under a changing theme (“Untold Narratives” this year). “It is my absolute favourite event. There are things to discover and also to buy. It is not a [non-commercial] biennale,” said participant Emanuel Layr. His group show, including work by PopeL, Jeanne Dunning and Puppies Puppies, is curated by the American artist Gaylen Gerber.

At Galerie Kandlhofer, a show based around the human body is organised by the independent curator Tevž Logar. “It really seems unique for commercial galleries to get [state] support. And having an outside curator means we can create something bold, outside of the gallery programme,” says gallery founder Lisa Kandlhofer. Curated By runs until October 19.

London gallerist Sid Motion has joined forces with Tom Cole, previously co-owner of The Sunday Painter and now an independent consultant, for a series of four exhibitions anchored in craft. Their first show, Dust to Dust, explores decay and renewal, and opens in Motion’s gallery on Saturday (until November 2). The exhibition combines clay work by Phoebe Cummings (from £2,000) with a loaned 1968 sisal (carpet) work by Magdalena Abakanowicz, shown alongside flower photographs made by Robert Mapplethorpe towards the end of his life ($35,000-$45,000, editions of 10).

Their collaboration provides “moments for more curatorial projects, with something a bit more fresh than, say, doing art fairs”, Motion says. Cole, who co-ran The Sunday Painter between 2015 and 2023, says: “I’ve worked on my own and I’ve been in collaborations, and the latter is much more preferable.”

FT : BASF’s conglomerate structure can’t take the strain

BASF’s conglomerate structure can’t take the strain
German chemicals group has been buffeted by high energy prices and hamstrung customers

A strong economy is a wonderful thing. It enables all sorts of industries to flourish — and companies to get away with all sorts of ramshackle corporate structures. Without such tailwinds, management teams have to sharpen their axe if they are to deliver any value at all.

That is one way to read the slow demise of the German industrial conglomerate. Thyssenkrupp spun off hydrogen and is engaged in a complex effort to carve out its steel business. Siemens has a fraction of the sprawl it once did. Bayer has kicked the can down the road on a mooted three-way break-up. The Covestro chemicals unit that it spun out in 2015 is being snapped up by Abu Dhabi’s Adnoc. 

BASF, with its six segments and 11 operating divisions, appears poised to join the fray. The German chemicals giant’s new-ish chief executive, Markus Kamieth, is reportedly considering the future of three divisions — agricultural solutions (pesticides and seeds) coatings (paint for cars) and battery materials. These made perhaps €15.5bn of sales in 2023, out of its total of nearly €70bn, and have been turned into separate legal entities. BASF sold its upstream oil and gas assets to Harbour Energy at the end of last year. 

It is easy to see why BASF may be tempted to restructure. High energy prices and hamstrung customers — witness the plight of German auto manufacturers — have hit sales and margins. It will be free cash flow negative after dividend distributions this year and next, thinks Bernstein. The stock is down nearly 30 per cent in the past five years.


The result is that BASF, at €42bn of market capitalisation, is trading on a 20 per cent discount to the sum of its parts, according to Berenberg analysis. It may not be the best time to extract value from agriculture — US farm profitability is forecast to decline — or car coatings, given the travails of the auto sector. But they are big businesses, with an EV of perhaps €25bn between them: setting them loose would help narrow the valuation gap.

Attractive though that might be, however, it would not solve BASF’s underlying strategic problem. Its chemicals division, which turns petroleum products into the base and intermediate molecules needed to make everything else, is seriously challenged. A big chunk of its production is in Europe, where energy prices are a multiple of those of its US and Asian competitors. The unit is in poor shape, with a 3.3 per cent return on capital employed last year, and more than €900mn of negative cash flow. BASF’s restructuring efforts will have to run deeper still.

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • SCS -6.6%
Other news:
  • PGNY -24.3% (significant client to terminate services agreement)
  • CRMT -10.9% ($65 mln stock offering)
  • VNDA -10.1% (provided an update on its tradipitant development program - FDA declines to approve Vanda's marketing application)
  • HE -3.8% (provides settlement update; entered into $250 mln Equity Distribution with respect to an at-the-market offering program)
  • KN -3.5% (signs a definitive agreement for the sale of the consumer MEMS Microphone Business; Updates Guidance)
  • HESM -2.6% (prices secondary offering of 11.0 mln shares)
  • ASND -1.3% (commences $300 mln ADS offering)
  • AHR -1.3% (prices offering of 17.4 mln shares of common stock at $23.55 per share)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • DRI +10.1%, NBTX +6.5%, FDS +2.5%, STRL +1.5% (guidance)
Other news:
  • EWTX +21.7% (announces top-line data of EDG-7500)
  • ALGS +14.1% (to announce topline results from Phase 2a HERALD Study)
  • MBLY +8.2% (Intel reaffirms majority stake in Mobileye, emphasizes focus on growth and autonomous driving leadership)
  • ACET +6.8% (announces ADI-001 clinical biomarker data from the Phase 1 GLEAN trial)
  • TRIB +6.7% (to initiate CGM market study in India in furtherance of intended collaboration with Bayer)
  • PLUG +5.7% (contracts with BP and Iberdrola JV to supply PEM electrolyzers in Spain; Launches an Equipment Lease Financing Platform - Plug is Targeting >$150 million from a Combination of Debt Leverage & Customer Financing Solutions)
  • TUSK +5.2% (wholly owned subsidiary, Cobra Acquisitions LLC, announces that previously disclosed Settlement Agreement with the Puerto Rico Electric Power Authority was approved by the Title III Court)
  • PHI +5% (provides litigation update-Court granted final approval to PLDT's case-ending settlement on Sept 17)
  • BLDR +4.1% (updates succession plan)
  • AMKR +3.2% (exec chairman to retire)
  • VST +2.7% (to acquire equity interests of Vistra Vision from minority investors, to become sole owner)
  • PLTR +2.3% (awarded $99.8 mln U.S. Army contract)
  • INTC +2.1% (Intel reaffirms majority stake in Mobileye, emphasizes focus on growth and autonomous driving leadership)
  • GOOG +2% (YouTube details AI updates; to start integrating Google DeepMind's most capable model for generating video, Veo, into YouTube Shorts later this year)
  • JCI +1.8% (launches update to Metasys)
  • SNDX +1.4% (INCY and SNDX announce NEJM publication of data from Pivotal AGAVE-201 trial)
  • TGT +1.4% (appoints Jim Lee as CFO)
  • QGEN +1.3% (expands QIAcuity digital PCR offering)
  • VSTO +1.2% (Board of Directors Is Committed to Exploring All Opportunities to Maximize the Value of Revelyst, Including a Potential Sale)
  • RGEN +1% (to restate results due to timing recognition of product revenue; increases FY24 revenue guidance)
  • INCY +1% (INCY and SNDX announce NEJM publication of data from Pivotal AGAVE-201 trial)

>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Air France-KLM (AFLYY) upgraded to Neutral from Underperform at Exane BNP Paribas
    • DoorDash (DASH) upgraded to Buy from Neutral at BTIG Research; tgt $155
    • Equifax (EFX) upgraded to Neutral from Underperform at Exane BNP Paribas; tgt $310
    • Equity Lifestyle Properties (ELS) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $82
    • Prelude Therapeutics (PRLD) upgraded to Buy from Neutral at H.C. Wainwright; tgt $5
    • Safehold (SAFE) upgraded to Outperform from Mkt Perform at Raymond James; tgt $34
  • Downgrades:
    • Athira Pharma (ATHA) downgraded to Neutral from Outperform at Mizuho; tgt lowered to $0.50
    • Casey's General (CASY) downgraded to Underweight from Neutral at JP Morgan; tgt raised to $337
    • Clear Channel Outdoor (CCO) downgraded/assumed at Equal Weight from Overweight at Wells Fargo; tgt lowered to $1.75
    • Elanco Animal Health (ELAN) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $15
    • Five Below (FIVE) downgraded to Underweight from Neutral at JP Morgan; tgt raised to $95
    • Halozyme Therapeutics (HALO) downgraded to Neutral from Overweight at JP Morgan; tgt raised to $57
    • Lument Finance Trust (LFT) downgraded to Mkt Perform from Outperform at Raymond James
    • Murphy USA (MUSA) downgraded to Underweight from Neutral at JP Morgan; tgt raised to $435
    • NexPoint Real Estate Finance (NREF) downgraded to Mkt Perform from Strong Buy at Raymond James
    • Progyny (PGNY) downgraded to Mkt Perform from Mkt Outperform at JMP Securities
    • Rentokil Initial plc (RTO) downgraded to Neutral from Buy at Redburn Atlantic
    • Vista Outdoor (VSTO) downgraded to Neutral from Buy at ROTH MKM; tgt $42
    • WillScot Mobile Mini (WSC) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $44
  • Others:
    • Abbott Labs (ABT) initiated with an Overweight at Piper Sandler; tgt $131
    • Avis Budget (CAR) initiated with an Equal Weight at Barclays; tgt $105
    • Centessa Pharmaceuticals (CNTA) initiated with a Buy at B. Riley Securities; tgt $33
    • Charter Comm (CHTR) initiated with a Sector Perform at RBC Capital Mkts; tgt $345
    • Coursera (COUR) initiated with a Buy at BofA Securities; tgt $11
    • Exelixis (EXEL) initiated with a Neutral at UBS; tgt $30
    • Global Medical REIT (GMRE) initiated with a Buy at Alliance Global Partners; tgt $12
    • Helix Energy (HLX) initiated with a Strong Buy at Raymond James; tgt $14
    • Hertz Global (HTZ) initiated with an Underweight at Barclays; tgt $3
    • HIVE Digital Technologies (HIVE) initiated with an Outperform at Northland Capital; tgt $5.50
    • Kodiak Gas Services (KGS) initiated with a Buy at Redburn Atlantic; tgt $35
    • Kosmos Energy (KOS) initiated with a Neutral at Mizuho; tgt $5
    • Lamar Advertising (LAMR) initiated with an Equal Weight at Wells Fargo; tgt $132
    • Merck KGaA (MKKGY) initiated with a Buy at Goldman
    • Myriad Genetics (MYGN) initiated with an Equal-Weight at Morgan Stanley; tgt $32
    • NextEra Energy (NEE) initiated with a Hold at Jefferies; tgt $87
    • NextEra Energy Partners (NEP) initiated with a Buy at Jefferies; tgt $28
    • Northern Oil & Gas (NOG) initiated with an Outperform at Mizuho; tgt $47
    • Oklo Inc. (OKLO) initiated with a Buy at B. Riley Securities; tgt $10
    • OUTFRONT Media (OUT) resumed with an Overweight at Wells Fargo; tgt $22
    • Quanta Services (PWR) initiated with an Outperform at Wolfe Research; tgt $313
    • Talos Energy (TALO) initiated with an Outperform at Mizuho; tgt $16
    • Turning Point Brands (TPB) initiated with a Buy at ROTH MKM; tgt $50
    • UBS AG (UBS) resumed with a Neutral at BofA Securities
    • Wave Life Sciences (WVE) initiated with a Buy at B. Riley Securities; tgt $11

>>> Oklo Inc.: Advanced Nuclear Company Advancing Customer Pipeline at Impressiv

Oklo Inc.: Advanced Nuclear Company Advancing Customer Pipeline at Impressive Rate— Initiating Coverage at Buy, $10 PT -- B. Riley Securities (6.22)
Analyst Ryan Pfingst said, "We are initiating coverage of Oklo Inc. (OKLO) with a Buy rating and a $10 price target based on our belief that the company's advanced nuclear technology will continue to garner customer interest and ultimately provide reliable, carbon-free power with attractive economics for end users. Oklo is pursuing an owner-operator model with the intention of selling power directly to customers under long-term contracts, unique in the nuclear industry. We believe Oklo's business model enables several key operational and regulatory advantages. Traditionally, large nuclear reactor developers sell or license their reactor designs to utilities that then construct and operate the plants. As the owner-operator, Oklo can pursue a combined license application (COLA) for design, construction, and operations together, likely reducing NRC approval timelines and regulatory costs. Oklo has shown impressive progress on the customer front, with its customer pipeline nearly doubling Y/Y from ~700 MW in July 2023 to 1,350 MW as of August 2024. The company is targeting its first deployment at Idaho National Laboratory (INL) in 2027, which will likely be the first advanced nuclear reactor to become operational. While the stock is likely to remain volatile given the long-term nature of the story, we believe potential near- to mid-term catalysts in the form of new customers, regulatory approvals, and project execution offer sources of potential upside."

>>> Europe : Brokers Upgrades & Downgrades - 19th of September 2024 V3(++)

>>> Up
* Air France-KLM Raised to Neutral at BNPP Exane; PT 9 euros
* BE Semiconductor Raised to Buy at Kempen & Co; PT 145 euros (++)
* BlackRock World Mining Raised to Buy at Stifel (+)
* F-Secure Raised to Buy at Nordea; PT 2.50 euros
* Indra Raised to Buy at Alantra Equities; PT 22 euros (+)
* IONOS Group SE Raised to Outperform at Oddo BHF; PT 27 euros
* Laurent-Perrier Raised to Outperform at Oddo BHF; PT 136 euros
* Pampa Energia ADRs Raised to Buy at Banco BTG Pactual; PT $80
* Portmeirion Raised to Buy at N+1 Singer; PT 250 pence (++)
* Trainline Raised to Neutral at BNPP Exane (+)
* United Utilities Raised to Buy at BofA (+)
* Vitec Software Group Raised to Buy at Nordea; PT 655 kronor

>>> Down
* Antofagasta Cut to Underweight at Morgan Stanley; PT 1,600 pence
* Asos Cut to Reduce at HSBC; PT 320 pence
* Blackstone Cut to Sell at CFRA; PT $140
* Detection Tech Oy Cut to Reduce at Inderes; PT 20 euros
* Deutsche Post Cut to Underperform at BNPP Exane (+)
* Deutsche Telekom Cut to Neutral at Oddo BHF; PT 27 euros (+)
* Lanson-BCC Cut to Neutral at Oddo BHF; PT 48 euros
* Prodways Cut to Reduce at Portzamparc; PT 51 euro cents (+)
* Rentokil Cut to Neutral at Redburn; PT 420 pence
* Vetoquinol Cut to Hold at TP ICAP Midcap; PT 94 euros (+)
* Vista Outdoor Cut to Neutral at Roth Capital Partners; PT $42
* Volvo Cut to Hold at DNB Markets; PT 285 kronor (+)

>>> Initiation
* Afentra PLC Rated New Buy at Canaccord; PT 80 pence (+)
* Aixtron Rated New Neutral at Kempen & Co; PT 17 euros (++)
* A.G. Barr Rated New Outperform at Davy; PT 770 pence (++)
* Alm Brand Rated New Buy at HSBC; PT 15.50 kroner
* Ashtead Reinstated Buy at Berenberg; PT 7,000 pence
* Avis Budget Rated New Equal-Weight at Barclays; PT $105 (+)
* Ctek Rated New Hold at Pareto Securities; PT 19 kronor
* De' Longhi Reinstated Neutral at BNPP Exane; PT 30 euros (+)
* Hertz Rated New Underweight at Barclays; PT $3 (+)
* Merck KGaA Reinstated Buy at Goldman; PT 205 euros
* Oklo Rated New Buy at B Riley; PT $10
* Primary Health Rated New Buy at Shore Capital; PT 120 pence (+)
* SEB Reinstated Outperform at BNPP Exane; PT 125 euros (+)

>>> Call
* Merck KGaA Gains as Goldman Sachs Gives Buy Recommendation (++)
* TI Fluid Systems Worth at Least 278p/Share: Canaccord’s Quest